June 5, 2012 - In research that has been labelled a 'game changer' in Triple Negative Breast Cancer treatment, Dr. Sandra Dunn's team at UBC identifies RSK as critical to the survival of TNBC stem cells that can drive disease recurrence.
Stem Cell Killer Could Lead to Triple-Negative Breast Cancer 'Game Changer'
Previous
Previous
Exploring Alcoholism Drug’s Potential Against Brain Tumors
Next
Next